Literature DB >> 21332115

Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases.

Rohan A Davis1, Andreas Hofmann, Asiah Osman, Rebecca A Hall, Fritz A Mühlschlegel, Daniela Vullo, Alessio Innocenti, Claudiu T Supuran, Sally-Ann Poulsen.   

Abstract

In order to discover novel probes that may help in the investigation and control of infectious diseases through a new mechanism of action, we have evaluated a library of phenol-based natural products (NPs) for enzyme inhibition against four recently characterized pathogen β-family carbonic anhydrases (CAs). These include CAs from Mycobacterium tuberculosis, Candida albicans, and Cryptococcus neoformans as well as α-family human CA I and CA II for comparison. Many of the NPs selectively inhibited the mycobacterial and fungal β-CAs, with the two best performing compounds displaying submicromolar inhibition with a preference for fungal over human CA inhibition of more than 2 orders of magnitude. These compounds provide the first example of non-sulfonamide inhibitors that display β over α CA enzyme selectivity. Structural characterization of the library compounds in complex with human CA II revealed a novel binding mode whereby a methyl ester interacts via a water molecule with the active site zinc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21332115     DOI: 10.1021/jm1013242

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Designing of phenol-based β-carbonic anhydrase1 inhibitors through QSAR, molecular docking, and MD simulation approach.

Authors:  Shahzaib Ahamad; Md Imtaiyaz Hassan; Neeraja Dwivedi
Journal:  3 Biotech       Date:  2018-05-14       Impact factor: 2.406

2.  Dichloro-naphthoquinone as a non-classical inhibitor of the mycobacterial carbonic anhydrase Rv3588c.

Authors:  M A Dallaston; S Rajan; J Chekaiban; M Wibowo; M Cross; M J Coster; R A Davis; A Hofmann
Journal:  Medchemcomm       Date:  2017-05-12       Impact factor: 3.597

3.  Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?

Authors:  Claudiu T Supuran
Journal:  Front Pharmacol       Date:  2011-07-05       Impact factor: 5.810

4.  Treatment of Bronchopleural Fistula with Carbolic Acid instilled through Bronchofiberscope in post-pulmonectomy patients.

Authors:  Zheng Wang; Han-Bing Yu; Quan Luo; Yong-Yu Liu
Journal:  J Cardiothorac Surg       Date:  2015-09-15       Impact factor: 1.637

Review 5.  Carbonic Anhydrase Inhibitors as Novel Drugs against Mycobacterial β-Carbonic Anhydrases: An Update on In Vitro and In Vivo Studies.

Authors:  Ashok Aspatwar; Jean-Yves Winum; Fabrizio Carta; Claudiu T Supuran; Milka Hammaren; Mataleena Parikka; Seppo Parkkila
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

6.  Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies.

Authors:  Ciro Milite; Giorgio Amendola; Alessio Nocentini; Silvia Bua; Alessandra Cipriano; Elisabetta Barresi; Alessandra Feoli; Ettore Novellino; Federico Da Settimo; Claudiu T Supuran; Sabrina Castellano; Sandro Cosconati; Sabrina Taliani
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

7.  Natural product polyamines that inhibit human carbonic anhydrases.

Authors:  Rohan A Davis; Daniela Vullo; Claudiu T Supuran; Sally-Ann Poulsen
Journal:  Biomed Res Int       Date:  2014-08-05       Impact factor: 3.411

Review 8.  Bioactive Natural Product and Superacid Chemistry for Lead Compound Identification: A Case Study of Selective hCA III and L-Type Ca2+ Current Inhibitors for Hypotensive Agent Discovery.

Authors:  Hélène Carreyre; Grégoire Carré; Maurice Ouedraogo; Clarisse Vandebrouck; Jocelyn Bescond; Claudiu T Supuran; Sébastien Thibaudeau
Journal:  Molecules       Date:  2017-05-31       Impact factor: 4.411

9.  Development of Thiazolidinones as Fungal Carbonic Anhydrase Inhibitors.

Authors:  Özlen Güzel-Akdemir; Simone Carradori; Rossella Grande; Kübra Demir-Yazıcı; Andrea Angeli; Claudiu T Supuran; Atilla Akdemir
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

Review 10.  Mycobacterium tuberculosis β-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs.

Authors:  Ashok Aspatwar; Visvaldas Kairys; Sangeetha Rala; Mataleena Parikka; Murat Bozdag; Fabrizio Carta; Claudiu T Supuran; Seppo Parkkila
Journal:  Int J Mol Sci       Date:  2019-10-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.